Non-Ionizing 6G Signals Accurately Classify Lung Diseases Without Contact
January 7, 2026
Brand Name :
EndaCof-DM
(United States) [Available] ,Glenmax PEB DM
(United States) [Available]Synonyms :
Class :
antitussives
Dosage Forms & Strengths
oral solution
(1mg-5mg-2.5mg)/5ml- brompheniramine-dextromethorphan-phenylephrine
4 teaspoons orally every 4hrs
Do not exceed 120 mL per day
Dosage Forms & Strengths
oral solution
(1mg-5mg-2.5mg)/5ml- brompheniramine-dextromethorphan-phenylephrine
Age: >12 years
4 teaspoons orally every 4hrs
Do not exceed 120 mL per day
may decrease the therapeutic effects
spironolactone and hydrochlorothiazide
It may enhance the risk of bleeding when combined with Decongestants
It may enhance the risk of bleeding when combined with Decongestants
It may enhance the risk of bleeding when combined with Decongestants
It may enhance the risk of bleeding when combined with Decongestants
It may enhance the risk of bleeding when combined with Decongestants
It may enhance the risk of adverse reactions when combined with Histamine antagonists
It may enhance the risk of adverse reactions when combined with Histamine antagonists
It may enhance the risk of adverse effects when combined with Decongestant
It may enhance the risk of adverse effects when combined with Decongestant
decongestant: they may increase the hypertensive effect of Alpha 2-Agonists
decongestant: they may increase the hypertensive effect of Alpha 2-Agonists
decongestant: they may increase the hypertensive effect of Alpha 2-Agonists
decongestant: they may increase the hypertensive effect of Alpha 2-Agonists
decongestant: they may increase the hypertensive effect of Alpha 2-Agonists
may diminish the serum concentration
spironolactone and hydrochlorothiazide
it may enhance the risk of nephrotoxicity when combined with Diuretics
it may enhance the risk of nephrotoxicity when combined with Diuretics
it may enhance the risk of nephrotoxicity when combined with Diuretics
it may enhance the risk of nephrotoxicity when combined with Diuretics
it may enhance the risk of nephrotoxicity when combined with Diuretics
It may enhance the risk of nephrotoxicity when combined with Dopamine agonists
It may enhance the risk of nephrotoxicity when combined with Dopamine agonists
It may enhance the risk of nephrotoxicity when combined with Dopamine agonists
It may enhance the risk of nephrotoxicity when combined with Dopamine agonists
It may enhance the risk of nephrotoxicity when combined with Dopamine agonists
It may enhance the risk of adverse effects when combined with Fluroquinolones
It may enhance the risk of adverse effects when combined with Fluroquinolones
It may enhance the risk of adverse effects when combined with Fluroquinolones
It may enhance the risk of adverse effects when combined with Fluroquinolones
It may enhance the risk of adverse effects when combined with Fluroquinolones
Adverse drug reactions:
Frequency Not Defined
Excitability
Restlessness
Headache
Hypertension
Dizziness
Drowsiness
Dry mouth, throat, and nose
Thickening of mucus in nose or throat GI disturbances
Reflex tachycardia
Pregnancy warnings:
Pregnancy Category: C
Breastfeeding warnings:
The release of the drug into the human breastmilk is known
Pregnancy Categories:
Patient Information Leaflet
Generic Name: brompheniramine, dextromethorphan and phenylephrine
Pronounciation: brome-fen-IR-a-meen, dex-troe-meth-OR-fan, fen-il-EFF-rin
Why do we use brompheniramine, dextromethorphan and phenylephrine?
brompheniramine, dextromethorphan and phenylephrine belong to the class antitussive used to treat the symptoms of allergy and cold